opioids

Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder

Scientific article

18 December 2024

Abstract Importance Amidst an unprecedented opioid epidemic, identifying neurobiological correlates of change with medication-assisted treatment of heroin use disorder is imperative. White matter impairments in individuals with heroin use...

Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails

Scientific article

24 September 2024

Abstract Importance In 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing...

Pharmacological and Behavioral Treatment of Opioid Use Disorder

Scientific article

1 April 2019

Abstract Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5 million needing treatment. The aim of this article is to provide a clinical overview of the key pharmacological and behavioral treatments...

Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus

Scientific article

28 February 2024

Abstract Background The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high...

New guidelines for the health management of opiates

7 November 2023

Washington, D.C.

United States

The Inter-American Commission on Control (CICAD), the Valencia, Spain City Council, and the Pan-American Health Organization (PAHO) invite you to join the webinar “New guidelines for the health management of opiates” this Tuesday, November 7, starting at 10:00 (Washington, DC time).

Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder

Guide

This 35-minute module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids.

Recognizing and Responding to Opioid Overdose; Safety and Naloxone Training

Webinar

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

Scientific article

7 August 2023

Discussion Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...

Fentanyl DrugFacts

Guide

Fentanyl is a powerful synthetic opioid that is similar to morphine but is 50 to 100 times more potent. It is a prescription drug that is also made and used illegally. Like morphine, it is a medicine that is typically used to treat patients...

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

News

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...